In collaboration with 

Title:  Empowering Pediatric Providers to Enhance Management of Type 2 Inflammatory Conditions in Children 

Release | Expiration: March 14, 2025 - July 15, 2026

Statement of Need: Pediatric Type 2 inflammatory diseases, including atopic dermatitis, eosinophilic esophagitis (EoE), and asthma, present significant challenges for healthcare providers due to their complex, multisystemic nature and the evolving therapeutic landscape. Many pediatricians, nurse practitioners, and physician assistants encounter gaps in knowledge related to early identification, assessment, and optimal management strategies. Furthermore, limitations in awareness of timely referrals to subspecialists and advancements in biologic therapies hinder the delivery of comprehensive patient care. This educational curriculum fosters peer-based learning through small-group, collaborative experiences that help pediatric clinicians recognize key clinical indicators, apply evidence-based management strategies, facilitate appropriate referrals, and effectively communicate treatment options to patients and families. By integrating real-world clinical insights, this initiative aims to enhance clinical proficiency and improve patient outcomes in pediatric Type 2 inflammatory diseases

Educational Objectives:

• IDENTIFY common comorbidities associated with Type 2 inflammatory diseases.  
• APPLY best practices to assess and evaluate patients for signs of Type 2 inflammatory diseases, focusing on high-risk indicators  
• INCREASE timely and appropriate referrals to subspecialists for patients with suspected Type 2 inflammatory disorders.  
• COMMUNICATE effectively with patients' families about the benefits of biologic treatments in managing Type 2 inflammatory conditions. 

Target Audience: Pediatric health care providers (pediatricians, pediatric NPs and PAs) 

Faculty: 

	Edwin H. Kim, MD, MS Associate Professor of Pediatrics and Medicine Division Chief, Pediatric Allergy and Immunology Director, UNC Food Allergy Initiative Program Director, Allergy and Immunology Fellowship Training Program University of North Carolina School of Medicine Disclosures: No relevant financial disclosures.
	Lacey L. Kruse, MD Attending Physician, Dermatology Associate Professor of Pediatrics-Dermatology Ann & Robert H. Lurie Children's Hospital of Chicago Northwestern University Feinberg School of Medicine Disclosures: No relevant financial disclosures.
	Alan P. Baptist, MD, MPH Professor of Internal Medicine Division Chief, Allergy and Immunology Henry Ford Health Disclosures: No relevant financial disclosures.

Technical Writer: Joshua Schectel, MD 

Disclosures: No relevant financial disclosures. 

Accredited Provider Disclosure:
None of the planners, reviewers, and AAAAI / GatherEd staff for this educational activity have relevant financial relationship(s) with ineligible companies to disclose. 

Disclosure of Financial Relationships Policy:
AAAAI adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. 

Accredited Provider & Accreditation Statements:

This activity is accredited through AAAAI.  

CME: The American Academy of Allergy Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 
 
CE: The American Academy of Allergy Asthma and Immunology (AAAAI) is a Provider approved by the California Board of Registered Nursing, Provider #10704. 

Credit Designation Statement: 
The AAAAI designates this activity for up to 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits:

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. 

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. 

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 5.00 hours of Category 1 credit for completing this program. 

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Unlabeled Use:
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient's medical condition. 
 
Disclaimer:
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AAAAI, RealCME, or GatherEd. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact cme@aaaai.org
 
Method of Participation/Instructions:

Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-assessment and evaluation, and have received a digital copy of your credit certificate.

In order to claim the maximum amount of credit available, you must complete all of the following:

• Baseline/Final Assessments: 30 minutes each for a total of 1.0 hour of CME
• Five Self Study Modules (5) - 10-15 minutes each for a total of 1.0 hour of CME
• Three Live Group Discussions (3) - 30 minutes each for a total of 1.50 hours of CME
• Two Group Challenges (2) -30 minutes each for a total of 1.0 hours of CME
• One Action Plan (1) development: 30 minutes for a total of up to 0.50 hour of CME

Privacy Statement:

AAAAI Privacy and Data Protection Policy for CME Programs

The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this event ("the Course"), to provide services that you have requested from AAAAI, and otherwise as you may expressly consent.

By providing consent, you are allowing AAAAI and our educational partners involved in this Course to process your personal data. AAAAI will collect and store information you provide in the Registration Form for the purposes of enabling us to register your attendance in this Course, to assist with administrative, planning, and marketing purposes, and to allow the compilation and analysis of statistics relevant to AAAAI and our educational partners.

The information you provide in the Registration Form and information provided at any other time during the Course, including without limitation any feedback obtained during the Course, will be used by AAAAI to offer, provide, and continue to improve this Course and other services. With your permission, AAAAI may disclose some information collected in the Registration Form, such as your name, organization, address, telephone and fax numbers, and email address to industry supporters (subject to conditions) for marketing purposes. AAAAI will also use your email address to communicate important information regarding this event and for marketing purposes for future events.

AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision, and improvement of the Course or where such purpose is permitted or required by law.

AAAAI emphasizes that industry supporters of the Course may request that you share your contact information for the purpose of participating in a sponsored event outside of the Course agenda. This data transaction is considered a direct transfer of your information to the industry supporter. AAAAI does not control the usage of information transferred this way and, as such, AAAAI shall not be held responsible for any misuse of your personal data retrieved by industry supporters. You have the option to decline an industry supporter’s request to share your contact information and can ask them questions about how they will use your personal data, how long it will be retained, and if they will share information with third parties.

Commercial Supporters: Sanofi and Regeneron